Literature DB >> 19040484

Liver retransplantation in children. A 21-year single-center experience.

Christophe Bourdeaux1, Andrea Brunati, Magda Janssen, Catherine de Magnée, Jean-Bernard Otte, Etienne Sokal, Raymond Reding.   

Abstract

In this study, the epidemiology and outcome of graft loss following primary pediatric liver transplantation (LT) were analysed, with the hypothesis that early retransplantation (reLT) might be associated with lower immunologic risks when compared with late reLT. Between March 1984 and December 2005, 745 liver grafts were transplanted to 638 children at Saint-Luc University Hospital, Brussels. Among them, a total of 90 children (14%) underwent 107 reLT, and were categorized into two groups (early reLT, n = 58; late reLT, n = 32), according to the interval between either transplant procedures (< or >30 days). Ten-year patient survival rate was 85% in recipients with a single LT, vs. 61% in recipients requiring reLT (P < 0.001). Ten-year patient survival rates were 59% and 66% for early and late reLT, respectively (P = 0.423), the corresponding graft survival rates being 51% and 63% (P = 0.231). Along the successive eras, the rate of reLT decreased from 17% to 10%, whereas progressive improvement of outcome post-reLT was observed. No recurrence of chronic rejection (CR) was observed after reLT for CR (0 of 19). Two children developed a positive cross-match at reLT (two of 10, 20%), both retransplanted lately for CR secondary to immunosuppression withdrawal following a post-transplant lymphoproliferative disease. In summary, the results presented could not evidence better results for late reLT when compared with early reLT. The former did not seem to be associated with higher immunologic risk, except for children having withdrawal of immunosuppression following the first graft.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040484     DOI: 10.1111/j.1432-2277.2008.00807.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

1.  Effect of cardiac output - guided hemodynamic management on acute lung injury in pediatric living donor liver transplantation.

Authors:  Xiao-Jing Dou; Qing-Ping Wang; Wei-Hua Liu; Yi-Qi Weng; Ying Sun; Wen-Li Yu
Journal:  World J Gastrointest Surg       Date:  2022-09-27

Review 2.  Treating inborn errors of liver metabolism with stem cells: current clinical development.

Authors:  Etienne Marc Sokal
Journal:  J Inherit Metab Dis       Date:  2014-03-26       Impact factor: 4.982

3.  The outcomes of pediatric liver retransplantation from a living donor: a 17-year single-center experience.

Authors:  Kohei Miura; Seisuke Sakamoto; Keita Shimata; Masaki Honda; Takashi Kobayashi; Toshifumi Wakai; Yasuhiko Sugawara; Yukihiro Inomata
Journal:  Surg Today       Date:  2017-04-22       Impact factor: 2.549

4.  Risk factors of silent allograft fibrosis 10 years post-pediatric liver transplantation.

Authors:  Jinsoo Rhu; Sang Yun Ha; Sanghoon Lee; Jong Man Kim; Gyu-Seong Choi; Jae-Won Joh; Suk-Koo Lee
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

Review 5.  The role of the gut microbiome in graft fibrosis after pediatric liver transplantation.

Authors:  Tian Qin; Jingyuan Fu; Henkjan J Verkade
Journal:  Hum Genet       Date:  2020-09-13       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.